[(1) The Deposit Agreement . The statements made on the face and reverse of this ADR are summaries of certain provisions of the Deposit Agreement and the Articles of Association Withdrawal of Deposited Securities (2) subject, however, in each case 2 subject however, in each case Upon satisfaction of each of the conditions specified above, the Depositary (i) shall as]
[(1) The Deposit Agreement . The statements made on the face and reverse of this ADR are summaries of certain provisions of the Deposit Agreement and the Articles of Association Withdrawal of Deposited Securities (2) subject, however, in each case 2 subject however, in each case Upon satisfaction of each of the conditions specified above, the Depositary (i) shall as]
[April 22, 2011 LLP LLP Bernstein & Pinchuk] [SearchMedia Confirms Form 6-K Required due to Bernstein & Pinchuk LLPs Joint Venture with Marcum LLP B&P had been engaged by the Company to audit its financial statements since May 2010 and provided its audit report for the Companys financial statements for the years ended December 31, 2009 and December 31, 2008. During these fiscal years and the subsequent interim] [FORM 6-K April 18, 2011 SearchMedia Holdings Limited Cayman Islands (Jurisdiction of incorporation or organization) 13F Central Modern Building x x n/a SearchMedia Holdings Limited Paul Conway Paul Conway Cheif Executive Officer Description 16.1 Letter to the SEC from Bernstein & Pinchuk dated April 22, 2011]
[April 22, 2011 LLP LLP Bernstein & Pinchuk] [SearchMedia Confirms Form 6-K Required due to Bernstein & Pinchuk LLPs Joint Venture with Marcum LLP B&P had been engaged by the Company to audit its financial statements since May 2010 and provided its audit report for the Companys financial statements for the years ended December 31, 2009 and December 31, 2008. During these fiscal years and the subsequent interim] [FORM 6-K April 18, 2011 SearchMedia Holdings Limited Cayman Islands (Jurisdiction of incorporation or organization) 13F Central Modern Building x x n/a SearchMedia Holdings Limited Paul Conway Paul Conway Cheif Executive Officer Description 16.1 Letter to the SEC from Bernstein & Pinchuk dated April 22, 2011]
[Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report. 54,305,961 common shares as of December 31, 2010 o x o x x o o o] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company] [Certification by the Chief Executive Officer I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Jacob Chik Keung Ho, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Certification by the Chief Executive Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 13 v219311_ex13-1.htm] [Certification by the Chief Financial Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 14 v219311_ex13-2.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (Form S−8 No. 333−161827) pertaining to the 2003 Stock Option Plan of Sinovac Biotech Ltd., of our reports dated April 22, 2011, with respect to the consolidated financial statements of Sinovac Biotech Ltd., and the effectiveness of internal control over financial reporting]
[Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report. 54,305,961 common shares as of December 31, 2010 o x o x x o o o] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company] [Certification by the Chief Executive Officer I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Jacob Chik Keung Ho, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Certification by the Chief Executive Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 13 v219311_ex13-1.htm] [Certification by the Chief Financial Officer 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 14 v219311_ex13-2.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (Form S−8 No. 333−161827) pertaining to the 2003 Stock Option Plan of Sinovac Biotech Ltd., of our reports dated April 22, 2011, with respect to the consolidated financial statements of Sinovac Biotech Ltd., and the effectiveness of internal control over financial reporting]
[FORM 20-F ¨ OR x For the fiscal year ended December 31, 2010 OR ¨ OR ¨ Actions Semiconductor Co., Ltd. N/A Cayman Islands (Jurisdiction of incorporation or organization) 15-1, No. 1, HIT Road Tangjia Zhuhai, Guangdong, 519085 The People’s Republic of China Pei-Fen (Patricia) Chou, Chief Financial Officer Telephone: +86-756-339-2353 Facsimile: +86-756-339-2256 (Name, Telephone, E-mail and/or Facsimile Number and] [LIST OF SUBSIDIARIES All subsidiaries do business under their legal name. Name of Company Place and date of incorporation/establishment Attributable equity interest held Principal activities Actions Semiconductor Co., Ltd. ("Actions Semiconductor Mauritius") Republic of Mauritius ("Mauritius") November 16, 2001 100 % Investment holding Actions Semiconductor Co., Ltd. ("Actions Semiconductor Zhuhai") PRC December 28, 2001 100 % Design and manu- facture] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Niccolo Chen, the Chief Executive Officer of Actions Semiconductor Co., Ltd., certify that: 1. I have reviewed this annual report on Form 20-F of Actions Semiconductor Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Pei-Fen (Patricia) Chou, the Chief Financial Officer of Actions Semiconductor Co., Ltd., certify that: 1. I have reviewed this annual report on Form 20-F of Actions Semiconductor Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a] [TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report. Niccolo Chen Chief Executive Officer Pei-Fen (Patricia) Chou Chief Financial Officer EX-13.1 7 v219194_ex13-1.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Deloitte Touche Tohmatsu Hong Kong April 22, 2011 EX-15.1 8 v219194_ex15-1.htm]
[Registration Statement on Form F-6 Registration No. 333-169278 [FORM OFR] Number:________ CUSIP NUMBER:__________ American Depositary Shares (each American Depositary Share representing the right to receiveone (1) Fully Paid ordinary share) AMERICAN DEPOSITARY RECEIPT FOR AMERICAN DEPOSITARY SHARES representing DEPOSITED ORDINARY SHARES of CHINA MING YANG WIND POWER LIMITED (Incorporated under the laws of theyman Islands)]
[Registration Statement on Form F-6 Registration No. 333-169278 [FORM OFR] Number:________ CUSIP NUMBER:__________ American Depositary Shares (each American Depositary Share representing the right to receiveone (1) Fully Paid ordinary share) AMERICAN DEPOSITARY RECEIPT FOR AMERICAN DEPOSITARY SHARES representing DEPOSITED ORDINARY SHARES of CHINA MING YANG WIND POWER LIMITED (Incorporated under the laws of theyman Islands)]
[CUSIP No. G39300 10 1 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) OO 5]
